The features of cholesterol crystal embolisation (CCE) 
The phenomenon of cholesterol crystal embolisation (CCE) is defined as dislodgement of separate cholesterol crystals (<200 ,um), as opposed to large atheromatous particles, This is the general picture of CCE in histological sections ofbiopsy specimens, of surgical specimens, and of post mortem tissue, in all of which both more and less advanced lesions can be seen at the same time. The cholesterol crystals are dissolved during the histotechnical procedure, leaving the pathognomonic needle shaped lacunae in the lumina of arterioles in the histological sections (Fig 1) .
The disseminated or local obstruction of small vessels gives rise to a highly variable clinical presentation due to the ensuing ischaemia, infarction, possible perforation, or repair reaction. 2 The effects of CCE range in severity from transient local ischaemia of the skin to failure of multiple organs in the multiple cholesterol emboli syndrome. In necropsy studies the prevalence of CCE ranges from 3%3 to 17-6%. 4 After 15 were known to have had hypertension, 13 had had a myocardial infarction, 1 1 had signs of coronary insufficiency, nine had intermittent claudication, eight had an aortabifurcation prosthesis, four suffered from diabetes mellitus, four had undergone an episode of ischaemic colitis, and three had earlier had blue toes.
In 59 patients (61-4%) no possibly provocative factors were mentioned. Among the remaining 37, 15 were taking oral anticoagulants, 15 had undergone aortic angiography, 12 had had surgery for rupture of an abdominal aneurysm, four had received coronary artery bypass grafts, and one had had thrombolytic therapy, all within eight weeks of the symptoms of CCE, These presenting symptoms are listed in Table II .
Of 12 patients in whom differentiation of white blood cells was reported, one showed eosinophilia of 15%.
Three of the eight patients in whom total serum cholesterol was reported had slightly raised values (7.0, 7.3, and 8.0 mmoIIl). Complement status was determined in one patient, and reported to be normal. All other reported laboratory findings were non-specific representatives of tissue damage and inflammation.
The diagnoses put forward by the respective clinicians as the most probable in advance of the histological confirmation of the presence of CCE, are listed in Table III. Specifications of the endoscopic and pathological appearance at the CCE site are listed in Table IV . No CCE sites outside the alimentary tract were mentioned in the reports of 63 patients (65.6%). In the other 33 patients, 77 sites were located, distributed over the kidneys (n=25), the spleen (n=12), the skin (n=9), -4) the liver (n=7), the pancreas (n=7), the adrenals (n= 3), the prostate (n= 3), the urinary bladder (n= 3), the gall bladder (n= 2), the muscles (n=2), the brain (n=2), the eye (n = 1), and the uterus (n = 1 With a mean of 129 850 deaths per year and a mean necropsy rate of 7d1%, this would point at a frequency of gastrointestinal CCE of 0-046%. With regard to the prevalence of atherosclerosis and the target positions of both kidney and alimentary tract, as well as the fact that CCE is often a multisystem disease, one might expect a higher incidence of renal CCE and a relatively higher incidence of gastrointestinal CCE. However, all that can be stated at this point is that the figures mentioned can represent either a low incidence or lack of awareness of clinically relevant CCE.
Addressing the latter issue we set out to increase our familiarity with the phenomenon by investigating the ways in which CCE to the alimentary tract manifests itself. We did this by reviewing unselected cases as they were uniformly filed in the national database. The finding of an age and sex distribution similar to that in patients with peripheral arteriosclerotic disease as a whole13 agrees with the suggested pathophysiology of CCE.1 The distribution of CCE sites in the alimentary tract (Table I) more or less represents the distribution of blood flow once it has passed the atheromatous large vessels, picking up the cholesterol crystals on its way. Several case reports described CCE to the stomach1417 the small intestine, [16] [17] [18] [19] [20] [21] and the colon.6 22-28 To our knowledge there have been no published reports of oesophageal CCE. The emboli, probably originating from the coeliac trunk, taken downstream by the left gastric artery and its oesophageal branches, caused an ulcer in one patient, and a chronic refractory oesophagitis in another. Other as yet unreported sites are the appendix and the anus, for both of which we found one example -the former in the shape of a granulomatous appendicitis, the latter leading to the formation of an anal ridge initially believed to be a malignant tumour.
In concordance with the pathophysiology and with earlier reports most patients had a history of atherosclerotic disease. In 38.6% of the reports we studied, a provocative factor could be identified, mostly oral anticoagulant treatment and aortic angiography. The classic clinical presentation emerging from our study is that of a patient with sudden abdominal pain, diarrhoea, gastrointestinal blood loss, renal failure, and skin abnormalities. This fullblown picture was mainly seen shortly after vascular manipulation when massive cholesterol crystal showers must have harassed the downstream tissues. Most patients, however, presented with isolated, often fluctuating, common gastrointestinal symptoms like a dull abdominal pain, dyspepsia, chronic anaemia due to occult blood loss, weight loss, a palpable mass, fistula, or ileus (Table II) . This is probably a result of spontaneous, chronic, intermittent cholesterol crystal scattering, giving rise to mucosal dysfunction or damage, which may be transient.
In our study a diagnosis of CCE before the histological examination was made in only 11 patients (Table III) . Another reason for this, beside a low index of suspicion or the presence of another disease explaining the symptoms, may be that the pathognomonic needle shaped clefts in the deeper submucosal arteries are either easily overlooked in histological sections or missed in superficial biopsy specimens.22 An early diagnosis was greatly facilitated by the presence of preceding or concomitant CCE manifestations in skin or kidneys.
We registered many gastro-intestinal diseases as later dismissed differential diagnoses (Table III) . Some of these were reported earlier, like ischaemic colitis due to other causes,29 malignancy,27 Crohn's disease,5 angiodysplasia,15 vasculitis,30 periarteritis nodosa,31 and rectal polyp.22 Much of this is due to the observed stages of mucosal damage and repair as well as granuloma formation (Table IV) , that may lead the clinician further astray when the CCE clefts go unnoticed or escape superficial sampling. The macroscopic lesions such as pseudopolyps, purple spots, erosions, stenosis, ulcers, and telangiectasia were noted at endoscopy, or by observing the resection specimen. Endoscopic photographs of purple discolourations and geographic whitish macules of the mucosa and of sessile polyps, all proved to be caused by CCE, have previously been published.32 33 In six patients, another cause (carcinoma in four and radiation effects in two) explained the symptoms, suggesting that CCE was a coincidental finding. Eosinophilia, earlier reported to accompany CCE to the kidneys,34 was seen in one of 12 patients in whom a white blood cell count was reported. Similarly, hypocomplementaemia35 was not found in the one patient tested. The raised serum cholesterol values found, probably represent a common risk factor for the development of atherosclerotic plaques commonly present in the studied population. The locations of the extraintestinal CCE sites we observed follow the same distribution as described in an earlier study of cases collected from published reports.' 1 Since we only searched for CCE to the alimentary tract, the cases of gall bladder, liver, and pancreas CCE we found were restricted to those in whom these were additional findings. Clinical expressions due to these locations were limited to two cases of acalculous cholecystitis in two patients with gall bladder CCE and one of pancreatitis in seven patients with CCE to the pancreas. The last finding suggests that CCE to the liver and the pancreas can be asymptomatic.
The retrospective nature of our study precludes a reliable statistical analysis of true incidence, treatment, and outcome figures. Answers concerning true incidence, however, will be hard to come by owing to the ethical objections to taking multiple biopsy specimens prospectively from high risk patients. Once the diagnosis of CCE is made the patient can be spared further diagnostic efforts and treatment can be adjusted. Consequent location and exclusion or excision of the emboli source, although earlier described as a seldomly reached objective,36 was recently reported to give excellent long term relief of embolisation in a series of 62 patients.37 Excision of the damaged tissue may give considerable, albeit only temporary relief, due to the often undulant but relentless course of the disease. The latter is illustrated by our finding of necropsy rapidly following biopsies and resections from the same patients.
In conclusion, studying clinical and pathological data of an unselected homogenous group of patients we found that common gastrointestinal symptoms can be caused by CCE. CCE was most seen in the colon. It was also observed as a coincidental finding. Its 
